Evidence map›Paper›PMID 31182853›Full record

ArticleNature reviews. Urology2019

Neisseria gonorrhoeae resistance driven by antibiotic use.

Huan V Dong, Jeffrey D Klausner

Abstract readNews
PubMed Publisher
In one paragraph

Article in Nature reviews. Urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  2. Article
  3. Detection ofAntibiotics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Evaluation ofInfection and drug resistance · 2022
    Article
  11. Article
  12. microLife · 2022
    Article
  13. Patients May Accurately Self-collect Pharyngeal and Rectal Specimens for Neisseria gonorrhoeae and Chlamydia trachomatis Infection: But Is There Benefit?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Huan V DongDepartment of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-6370-1811
Jeffrey D KlausnerDivision of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. JDKlausner@mednet.ucla.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsDrug UtilizationHumansNeisseria gonorrhoeaeAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.